Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
24 janv. 2023 08h00 HE
|
Nemaura Medical, Inc
Average weight loss of 3.7 pounds and an average BMI reduction of 0.6 after 10 weeks in initial patients LOUGHBOROUGH, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:...
Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference
11 janv. 2023 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
01 déc. 2022 08h15 HE
|
Nemaura Medical, Inc
Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
29 nov. 2022 08h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
12 oct. 2022 11h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and...
Nemaura Medical to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
04 oct. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable...
Nemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment Conference
06 sept. 2022 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable...
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
15 août 2022 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
21 juil. 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, July 21, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
30 juin 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...